Exploring Menopause, aging and Physiological Outcomes in Women with Intellectual And/or Neurodevelopmental Disabilities
Summary
This study looks at how lifestyle choices like exercise and diet, along with certain genes called HERVs, affect aging and telomere length in individuals with intellectual and developmental disabilities. It will explore whether healthy habits can help slow down early aging in this population, who often face more health problems, like early menopause. By examining how these habits impact telomere length and whether HERV expression can show signs of early aging, researchers aim to help healthcare professionals and caregivers create personalized care plans to support healthy aging.
Eligibility
Eligible ages: 25 to 100
Accepts healthy participants: Yes
Inclusion criteria:
Individuals who
1) Have or have had a womb
2) Aged 25 years or older
3) Identify as having an Intellectual Disability AND/OR Down Syndrome, OR as Neurotypical
Exclusion criteria:
You are not eligible to participate if you are
1) Unable to provide informed consent and/or assent
2) Unable to provide consent for a blood sample
3) Have a severe illness or hospitalization at the time of recruitment
4) Have HIV, HCV, HBV, or other immunocompromising conditions
5) Currently on antibiotics or immunosuppressive therapy
6) Have other conditions that may affect study outcomes, such as severe illness, narcotic addiction, or pregnancy
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
For more information or to participate, please contact Dr. Laura St. John by email at laura.stjohn@ucalgary.ca or by phone at 403-220-8954.
Principal investigator:
Laura St.John
Clinical trial:
No
REB-ID:
REB25-0050